Biology Reference
In-Depth Information
SA. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune re-
sponses in mucosal tissue. Immunity 12: 495±503.
Cyster JG. 1999. Chemokines and cell migration in secondary lymphoid organs. Science 286: 2098±
2102.
De Rossi A, Roncella S, Calabro ML, D'Andrea E, Pasti M, Panozzo M, Mammano F, Ferrarini
M, Chieco-Bianchi L. 1990. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells
by the human immunode®ciency virus: evidence for a persistent and productive infection leading
to B cell phenotypic changes. Eur J Immunol 20: 2041±2049.
Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P. 1998. CD4 T cell cytokine di¨erenti-
ation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4
and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 188: 297±304.
Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine recep-
tor, BLR1, directs B cell migration to de®ned lymphoid organs and speci®c anatomic compart-
ments of the spleen. Cell 87: 1037±1047.
Forster R, Schweigard G, Johann S, Emrich T, Kremmer E, Nerl C, Lipp M. 1997. Abnormal ex-
pression of the B-cell homing chemokine receptor BLR1 during the progression of acquired
immunode®ciency syndrome. Blood 90: 520±525.
Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M. 1999. CCR7
coordinates the primary immune response by establishing functional microenvironments in sec-
ondary lymphoid organs. Cell 99: 23±33.
Fox CH, Tenner-Racz K, Firpo A, Pizzo PA, Fauci AS. 1991. Lymphoid germinal centers are res-
ervoirs of human immunode®ciency virus type 1 RNA. J Infect Dis 164: 1051±1057.
Frankel AD, Pabo CO. 1988. Cellular uptake of the tat protein from human immunode®ciency
virus. Cell 55: 1189±1193.
Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS,
Gribben JG, Nadler LM. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals,
since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:
523±532.
French DL, Laskov R, Schar¨ MD. 1989. The role of somatic hypermutation in the generation of
antibody diversity. Science 244: 1152±1157.
Friedler A, Friedler D, Luedtke NW, Tor Y, Loyter A, Gilon C. 2000. Development of a functional
backbone cyclic mimetic of the HIV-1 tat arginine-rich motif [In Process Citation]. J Biol Chem
275: 23783±23789.
Fritsch L, Marechal V, Schneider V, Barthet C, Rozenbaum W, Moisan-Coppey M, Coppey J,
Nicolas JC. 1998. Production of HIV-1 by human B cells infected in vitro: characterization of an
EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection.
Virology 244: 542±551.
Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfe¨er K. 1998. The lymphotoxin beta receptor
controls organogenesis and a½nity maturation in peripheral lymphoid tissues. Immunity 9: 59±
70.
Gallo RC. 1999. Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat)
toxoid as an important component of a vaccine. Proc Natl Acad Sci USA 96: 8324±8326.
Giachino C, Padovan E, Lanzavecchia A. 1998. Re-expression of RAG-1 and RAG-2 genes and
evidence for secondary rearrangements in human germinal center B lymphocytes. Eur J Im-
munol 28: 3506±3513.
Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ. 1998. The sequential role of
lymphotoxin and B cells in the development of splenic follicles. J Exp Med 187: 997±1007.
Goodnow CC, Cyster JG. 1997. Lymphocyte homing: the scent of a follicle. Curr Biol 7: R219±
R222.
